VERTEX PHARMACEUTICALS INC's ticker is and the CUSIP is 92532F950. A total of 6 filers reported holding VERTEX PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,629,000 | +75.5% | 14,900 | +18.3% | 0.01% | +200.0% |
| Q4 2016 | $928,000 | +94.1% | 12,600 | +231.6% | 0.00% | +100.0% |
| Q4 2015 | $478,000 | -85.7% | 3,800 | -88.2% | 0.00% | -85.7% |
| Q3 2015 | $3,353,000 | +78.6% | 32,200 | +111.8% | 0.01% | +75.0% |
| Q2 2015 | $1,877,000 | +118.0% | 15,200 | +108.2% | 0.01% | +100.0% |
| Q1 2015 | $861,000 | -60.2% | 7,300 | -59.9% | 0.00% | -55.6% |
| Q4 2014 | $2,162,000 | -2.8% | 18,200 | -8.1% | 0.01% | 0.0% |
| Q3 2014 | $2,224,000 | -16.1% | 19,800 | -29.3% | 0.01% | -25.0% |
| Q2 2014 | $2,651,000 | -17.1% | 28,000 | -38.1% | 0.01% | -14.3% |
| Q1 2014 | $3,197,000 | -5.2% | 45,200 | -0.4% | 0.01% | +16.7% |
| Q4 2013 | $3,373,000 | -11.4% | 45,400 | -9.6% | 0.01% | -7.7% |
| Q3 2013 | $3,806,000 | -61.2% | 50,200 | -59.0% | 0.01% | -63.9% |
| Q2 2013 | $9,799,000 | – | 122,400 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 55,400 | $12,130,000 | 0.08% |
| SIMPLEX TRADING, LLC | 668 | $14,625,000 | 0.03% |
| Maven Securities LTD | 1,000 | $217,000 | 0.02% |
| Allianz Asset Management GmbH | 53,700 | $11,758,000 | 0.01% |
| HBK INVESTMENTS L P | 4,700 | $1,029,000 | 0.01% |
| JPMORGAN CHASE & CO | 46,300 | $10,137,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |